🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 116 of 173

  1. US 8236987

    Selective estrogen receptor modulator compositions and methods for treatment of disease

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8236925

    Protein nanorings

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8236350

    Polymer for tissue engineering applications and drug delivery

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8232320

    Antimicrobial nanoemulsion compositions and methods

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8232448

    Transgenic mouse with a homozygous mutation in the CMAH gene

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8232068

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8232275

    2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8227583

    Vaccines containing canine parvovirus genetic variants

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8227432

    Transposon system and methods of use

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8222257

    Phosphono-pent-2-en-1-yl nucleosides and analogs

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8222293

    Treating learning deficits with inhibitors of Hmg CoA reductase

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8222392

    Kit for detection of telomerase reverse transcriptase nucleic acids

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8222289

    Salinosporamides and methods for use thereof

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8222242

    Nitric oxide releasing compounds

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8222015

    Heat resistant bioactive composition

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8221763

    Yeast-antigen compositions and methods of using the same

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8222288

    Small molecule inhibitors of MDM2 and the uses thereof

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8216593

    Parasite vaccine

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8216594

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8217072

    Salinosporamides and methods for use thereof

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8216580

    Sulfatases and methods of use thereof

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8212009

    Methods and compounds for lymphoma cell detection and isolation

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8212104

    Model of experimentally induced chronic pain and uses thereof

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8211934

    Small molecule inhibition of PDZ-domain interaction

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8211649

    Methods of diagnosing and prognosing hodgkin's lymphoma

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8211635

    P53 modulator and cancer target

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8211664

    Methods and materials for making simvastatin and related compounds

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8212007

    Expression and purification of HIP/PAP and uses therefor

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8211876

    Compositions for treatment of inflammatory diseases

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8207228

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8206332

    Indwelling heat exchange catheter and method of using same

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8207120

    NELL-1 enhanced bone mineralization

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8206724

    Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8206700

    Methods and compositions for treating tularemia

    Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8202844

    Indole antiviral compositions and methods

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8203030

    Transgenic mouse models for diseases caused by mtDNA mutations and related methods

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8202902

    Bivalent SMAC mimetics and the uses thereof

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8202549

    Mesocellular oxide foams as hemostatic compositions and methods of use

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8202507

    Assay for vitamin B12 absorption and method of making labeled vitamin B12

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8202848

    Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8198255

    SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8198254

    Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8197838

    Sustained release systems of ascorbic acid phosphate

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8197870

    Depolymerization extraction of compounds from birch bark

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8197818

    EML4-ALK fusion gene

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.